Home/Filings/4/0001062993-25-001606
4//SEC Filing

Toth Christopher A. 4

Accession 0001062993-25-001606

CIK 0000010456other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:03 PM ET

Size

5.6 KB

Accession

0001062993-25-001606

Insider Transaction Report

Form 4
Period: 2025-01-31
Toth Christopher A.
EVP, Group Pres, Kidney Care
Transactions
  • Tax Payment

    Common Stock, $1 par value

    2025-01-31$32.56/sh25,372$826,112105,186 total
Footnotes (2)
  • [F1]Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on January 31, 2025 from the settlement of restricted stock units granted on March 6, 2024. These shares vested on January 31, 2025 in accordance with the terms of that Equity Purchase Agreement, dated as of August 12, 2024 (as amended), by and among Baxter International Inc. and certain Carlyle affiliates (the "EPA").
  • [F2]Adjusted to reflect (i) automatic reinvestment of dividends, and (ii) the number of shares forfeited by the reporting person in connection with the closing of the EPA, as further described in the Issuer's Form 8-K filed on February 3, 2025.

Issuer

BAXTER INTERNATIONAL INC

CIK 0000010456

Entity typeother

Related Parties

1
  • filerCIK 0001753950

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:03 PM ET
Size
5.6 KB